Cancer Family
Head and Neck Neoplasm
CI-CAN-00000021Explore in graph →
Non-malignant1,574 active trials17 approved drugs142 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000021Explore in graph →
Clinical trials
6,377 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02274155 | Anti-OX40 Antibody in Head and Neck Cancer Patients | completed | Phase 1 | 17 | Providence Health & ServicesOTHER | 1 | Feb 7, 2024 | clinicaltrials |
| NCT03549494 | Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction | completed | Phase 2 | 45 | Catalysis SLINDUSTRY | 1 | Feb 7, 2024 | clinicaltrials |
| NCT00390325 |
| Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer |
| completed |
| Phase 2 |
| 21 |
| National Cancer Institute (NCI)NIH |
| 1 |
| Feb 6, 2024 |
| clinicaltrials |
| NCT05564286 | Triple Antiemetic Regimen for Chemoradiotherapy in Cervical Cancer or Nasopharyngeal Cancer | completed | Phase 3 | 116 | Shantou University Medical CollegeOTHER | 1 | Feb 6, 2024 | clinicaltrials |
| NCT06243965 | Is Desmoplastic Stromal Reaction Useful to Modulate Lymph Node Dissection in Sporadic Medullary Thyroid Carcinoma?(DSR-MTC) | completed | — | 246 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Feb 6, 2024 | clinicaltrials |
| NCT06244394 | Retrospective Study on the Prediction of Radiation-induced Brain Injury in Patients With Nasopharyngeal Carcinoma | completed | — | 230 | Jiangsu Cancer Institute & HospitalOTHER | 1 | Feb 6, 2024 | clinicaltrials |
| NCT04698499 | Swallowing Therapy With the Assistance of a Mobile Health Device in Head and Neck Cancer Patients: a Pan-Alberta Study | completed | N/A | 18 | University of AlbertaOTHER | 1 | Feb 5, 2024 | clinicaltrials |
| NCT05918224 | Streptococcus Salivarius K12 for Prevention and Treatment of Oral Mucositis in Patients Undergoing Radiotherapy | completed | Phase 2 | 160 | West China HospitalOTHER | 1 | Feb 5, 2024 | clinicaltrials |
| NCT04608773 | Blinded Dry Mouth Spray Crossover Study | completed | N/A | 129 | Jonas JohnsonOTHER | 1 | Feb 1, 2024 | clinicaltrials |
| NCT05936502 | Ascertaining the Radiologic Prognostic Importance of Extranodal Extension on Imaging (iENE) in Head and Neck Cancer(EPIC-iENE DATA) | completed | — | 3,500 | Head and Neck Cancer International GroupOTHER | 8 | Feb 1, 2024 | clinicaltrials |
| NCT03691207 | A Study Of AL101In Patients With Adenoid Cystic Carcinoma (ACC) Bearing Activating Notch Mutations(ACCURACY) | completed | Phase 2 | 87 | Ayala Pharmaceuticals, Inc,INDUSTRY | 6 | Jan 31, 2024 | clinicaltrials |
| NCT01437449 | Docetaxel, Cisplatin, and Cetuximab (TPC) in Palliative Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck (SCCHN) | completed | Phase 2 | 27 | Stanford UniversityOTHER | 1 | Jan 30, 2024 | clinicaltrials |
| NCT02367859 | Dabrafenib and Trametinib in Treating Patients With BRAF Mutated Ameloblastoma | completed | Phase 2 | 1 | Stanford UniversityOTHER | 1 | Jan 30, 2024 | clinicaltrials |
| NCT02369835 | Modified Dakin's Solution in Reducing Radiation-Induced Dermatitis in Patients With Head and Neck Cancer Undergoing Radiation Therapy | completed | Phase 3 | 132 | Stanford UniversityOTHER | 1 | Jan 30, 2024 | clinicaltrials |
| NCT02609386 | IRX-2 Regimen in Patients With Newly Diagnosed Stage II, III, or IVA Squamous Cell Carcinoma of the Oral Cavity(INSPIRE) | completed | Phase 2 | 105 | Brooklyn ImmunoTherapeutics, LLCINDUSTRY | 4 | Jan 30, 2024 | clinicaltrials |
| NCT03266276 | Assessing Impact of CCO's PSO & PC Pathway in Ambulatory HNC Clinics | completed | N/A | 98 | Sunnybrook Health Sciences CentreOTHER | 1 | Jan 26, 2024 | clinicaltrials |
| NCT05056064 | Efficacy of Swallowing Function After Early Postoperative Oral Exercise Among Patient With Oral Cavity Cancer Underwent Flap Reconstruction | completed | N/A | 90 | Department of Medical Services Ministry of Public Health of ThailandOTHER_GOV | 1 | Jan 25, 2024 | clinicaltrials |
| NCT03511391 | CHEckpoint Inhibition in Combination With an Immunoboost of External Beam Radiotherapy in Solid Tumors(CHEERS) | completed | Phase 2 | 99 | University Hospital, GhentOTHER | 1 | Jan 23, 2024 | clinicaltrials |
| NCT03543813 | PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL | completed | Phase 1 / Phase 2 | 133 | CytomX TherapeuticsINDUSTRY | 4 | Jan 23, 2024 | clinicaltrials |
| NCT02244463 | A Phase I/II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer and Incurably Poorly Differentiated or Radioidodine Refractory Differentiated Thyroid Cancer | completed | Phase 1 / Phase 2 | 46 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 12, 2024 | clinicaltrials |
| NCT00342446 | A Follow-up Study of Women Evaluated and Treated for Infertility | completed | — | 12,193 | National Cancer Institute (NCI)NIH | 1 | Jan 11, 2024 | clinicaltrials |
| NCT02865135 | Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer | completed | Phase 1 / Phase 2 | 11 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 11, 2024 | clinicaltrials |
| NCT02718820 | Pembrolizumab Plus Docetaxel for the Treatment of Recurrent or Metastatic Head and Neck Cancer | completed | Phase 1 / Phase 2 | 22 | Medical University of ViennaOTHER | 1 | Jan 9, 2024 | clinicaltrials |
| NCT04145180 | Effectiveness of a Physical Recovery Program for Head and Neck Cancer Patients (3C-CUIDATE)(3C-CUIDATE) | completed | N/A | 55 | Universidad de GranadaOTHER | 1 | Jan 9, 2024 | clinicaltrials |
| NCT03157674 | Real-World Evidence and Treatment Patterns: Head and Neck Cancer | completed | — | 43,994 | Bristol-Myers SquibbINDUSTRY | 1 | Jan 5, 2024 | clinicaltrials |
| NCT04437030 | Multiparametric Photoacoustic Imaging in the Course of Radiation Therapy of Malignant Head and Neck Tumors | completed | N/A | 30 | University Hospital HeidelbergOTHER | 1 | Jan 5, 2024 | clinicaltrials |
| NCT02647021 | Therapeutic Resistance Group Exercise Training for Head & Neck Cancer Survivors(TARGET) | completed | N/A | 60 | University of AlbertaOTHER | 1 | Jan 3, 2024 | clinicaltrials |
| NCT04758026 | H&N Cancer; Survivorship and Late Effects | completed | — | 265 | Oslo University HospitalOTHER | 1 | Jan 3, 2024 | clinicaltrials |
| NCT03749460 | Nivolumab and Ipilimumab and Stereotactic Body Radiation Therapy in Treating Patients With Salivary Gland Cancers | completed | Phase 1 / Phase 2 | 20 | University of WashingtonOTHER | 1 | Dec 29, 2023 | clinicaltrials |
| NCT02757222 | Dose Escalation Versus Standard in Laryngopharyngeal Cancers(INTELHOPE) | completed | N/A | 100 | Tata Medical CenterOTHER | 1 | Dec 28, 2023 | clinicaltrials |
| NCT01709435 | Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors | completed | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 2 | Dec 22, 2023 | clinicaltrials |
| NCT02379039 | Multimodal Monitoring of Radiotherapy Response in Squamous Cell Cancer(MORRIS) | completed | — | 118 | Umeå UniversityOTHER | 1 | Dec 22, 2023 | clinicaltrials |
| NCT03219268 | A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms | completed | Phase 1 | 277 | MacroGenicsINDUSTRY | 8 | Dec 21, 2023 | clinicaltrials |
| NCT03454451 | CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers | completed | Phase 1 | 117 | Corvus Pharmaceuticals, Inc.INDUSTRY | 2 | Dec 21, 2023 | clinicaltrials |
| NCT02482168 | Study of the CD40 Agonistic Monoclonal Antibody APX005M | completed | Phase 1 | 43 | Apexigen America, Inc.INDUSTRY | 1 | Dec 20, 2023 | clinicaltrials |
| NCT03894891 | Induction TPN Followed by Nivolumab With Radiation in Locoregionally Advanced Laryngeal and Hypopharyngeal Cancer | completed | Phase 2 | 6 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 20, 2023 | clinicaltrials |
| NCT05793957 | Use of Virtual Reality Goggles During Chemotherapy Infusion to Reduce Anxiety-Related Symptoms | completed | N/A | 50 | OHSU Knight Cancer InstituteOTHER | 1 | Dec 19, 2023 | clinicaltrials |
| NCT06016335 | MRI-based Synthetic CT Images of the Head and Neck | completed | N/A | 80 | Amsterdam UMC, location VUmcOTHER | 1 | Dec 19, 2023 | clinicaltrials |
| NCT02678091 | Ultrasound Exam With Doppler for the Etiological Diagnosis of Orbital Masses (PUCE)(PUCE) | completed | N/A | 124 | Fondation Ophtalmologique Adolphe de RothschildNETWORK | 1 | Dec 18, 2023 | clinicaltrials |
| NCT06171464 | Prognostic Value of Pre-therapy 18F-FDG PET/CT for the Outcome of 18 FDG PET-guided SIB-IMRT in Patients With Head and Neck Cancer | completed | — | 19 | IRCCS San RaffaeleOTHER | 0 | Dec 14, 2023 | clinicaltrials |
| NCT04379505 | Palliative Expeditiously Adaptive Quad Shot Radiation Therapy (PEAQ-RT)(PEAQ-RT) | completed | N/A | 10 | Washington University School of MedicineOTHER | 1 | Dec 8, 2023 | clinicaltrials |
| NCT04040166 | Carotid PET/MRI With DOTATATE in Patients Post Head and Neck Radiation Therapy | completed | N/A | 20 | University Health Network, TorontoOTHER | 1 | Dec 7, 2023 | clinicaltrials |
| NCT05137639 | Free Skin Grafting to Reconstruct Donor Sites After Radial Forearm Flap Harvesting | completed | N/A | 32 | Wuerzburg University HospitalOTHER | 1 | Dec 7, 2023 | clinicaltrials |
| NCT03229278 | Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma | completed | Phase 1 | 14 | Rutgers, The State University of New JerseyOTHER | 1 | Dec 6, 2023 | clinicaltrials |
| NCT05226065 | The Relationship Between Intake of Macro and Micronutrients With Clinical Outcomes of Head and Neck Cancer Patients | completed | — | 112 | Indonesia UniversityOTHER | 1 | Dec 6, 2023 | clinicaltrials |
| NCT06152055 | Clinicopathological Profile of Head and Neck Cancers in Army Hospital of Nepal | completed | — | 76 | Tribhuvan University, NepalOTHER | 1 | Nov 30, 2023 | clinicaltrials |
| NCT01172470 | Phase II Trial of Pemetrexed-Based Induction Chemotherapy Followed by Concomitant Chemoradiotherapy in Previously Irradiated Head and Neck Cancer Patients | completed | Phase 2 | 34 | University of ChicagoOTHER | 1 | Nov 29, 2023 | clinicaltrials |
| NCT01185158 | A Phase II Study of 250-mg ZD1839 Monotherapy in Recurrent or Metastatic or Both Recurrent and Metastatic Squamous Cell Carcinoma | completed | Phase 2 | 46 | University of ChicagoOTHER | 1 | Nov 29, 2023 | clinicaltrials |
| NCT01187472 | Organ Preservation in the Multispeciality Therapy of Stage II-IV Locally Advanced Head and Neck Cancer | completed | — | 35 | University of ChicagoOTHER | 1 | Nov 29, 2023 | clinicaltrials |
| NCT03284775 | Intraoperative Ultrasound in Patients Undergoing Transsphenoidal Surgery for Pituitary Adenoma | completed | N/A | 5 | University College, LondonOTHER | 1 | Nov 29, 2023 | clinicaltrials |
Data updated 24 days agoSource updated Feb 7, 2024source: clinicaltrials